The assumption of molecular epidemiology that carcinogens leave fingerprint
s has suggested that analysis of the frequency, type, and site of mutations
in genes frequently altered in carcinogenesis may provide clues to the ide
ntification of the factors contributing to carcinogenesis. In this mini-rev
iew, we revise the development, and validation of the yeast-based p53 funct
ional assay as a new tool for molecular epidemiology. We show that this ass
ay has some very interesting virtues but also has some drawbacks. The yeast
functional assay can be used to determine highly specific mutation fingerp
rints in the human p53 cDNA sequence. Discrimination is possible when compa
ring mutation spectra induced by sufficiently different mutagens, However,
we also reported that the same carcinogen may induce distinguishable mutati
on spectra due to known influencing factors. (C) 2000 Elsevier Science B.V.
All rights reserved.